RxDoctor Payments Data

Henry Yampolsky, MD

Radiation Oncology · West Hills, CANPI 1295704237

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (51.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. AstraZeneca accounts for 85.1% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $16,523 and has fallen 98.8% since, to $195 in 2024. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$22,643in general payments, 2019–2025

Across 47 payments — averaging $481.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$19K
  • Astellas Pharma Global Development$1K
  • Varian Medical Systems, Inc.$805
  • Reflexion Medical, Inc.$330
  • Elekta, Inc.$297
  • Teleflex LLC$157
  • plus $290 from 6 others

What the payments were for

  • Consulting fees$6,53429%
  • Speaking & faculty fees$11,55051%
  • Travel & lodging$2,54111%
  • Food & beverage$2,0189%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$22,643 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California →

Medicare billing

Part B allowed, 2024
$995,499
Medicare patients
145
Services billed
3,613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OrgovyxRelugolix21$52,353
Tamsulosin Hcl54$415

Paid to pharmacies, not to this prescriber.

Other radiation oncology in West Hills

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →